These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26964561)

  • 1. Role of apolipoprotein B100 and oxidized low-density lipoprotein in the monocyte tissue factor induction mediated by anti-β2 glycoprotein I antibodies.
    Otomo K; Amengual O; Fujieda Y; Nakagawa H; Kato M; Oku K; Horita T; Yasuda S; Matsumoto M; Nakayama KI; Hatakeyama S; Koike T; Atsumi T
    Lupus; 2016 Oct; 25(12):1288-98. PubMed ID: 26964561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V; Bison E; Ruffatti A; Iliceto S
    Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome: 30 years and our contribution.
    Koike T
    Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of TLR4 in oxidized LDL/β2GPI/anti-β2GPI-induced transformation of macrophages to foam cells.
    Zhang X; Xie Y; Zhou H; Xu Y; Liu J; Xie H; Yan J
    J Atheroscler Thromb; 2014; 21(11):1140-51. PubMed ID: 24998486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway.
    Xu Y; Kong X; Zhou H; Zhang X; Liu J; Yan J; Xie H; Xie Y
    Thromb Res; 2014 Aug; 134(2):384-92. PubMed ID: 24882274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
    Romero FI; Amengual O; Atsumi T; Khamashta MA; Tinahones FJ; Hughes GR
    Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
    Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome.
    Kolyada A; Karageorgos I; Mahlawat P; Beglova N
    FEBS J; 2015 Mar; 282(5):864-73. PubMed ID: 25546421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
    Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
    Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.
    George J; Gilburd B; Hojnik M; Levy Y; Langevitz P; Matsuura E; Koike T; Shoenfeld Y
    J Immunol; 1998 Apr; 160(8):3917-23. PubMed ID: 9558098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Campello E; Hoxha A; Fedrigo M; Punzi L; Simioni P
    Clin Chem Lab Med; 2015 Jun; 53(7):1083-9. PubMed ID: 25720075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome.
    George J; Blank M; Levy Y; Meroni P; Damianovich M; Tincani A; Shoenfeld Y
    Circulation; 1998 Mar; 97(9):900-6. PubMed ID: 9521339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
    Biasiolo A; Rampazzo P; Brocco T; Barbero F; Rosato A; Pengo V
    Lupus; 1999; 8(2):121-6. PubMed ID: 10192506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.